Piper Sandler maintains Overweight rating on Cigna Group, $370 price target
Piper Sandler kept an Overweight rating on Cigna Group with a $370 price target, suggesting a 38.1% upside from the Oct 1 close. The firm highlights Cigna's long-term EPS growth outlook of 10-14% and a $3B efficiency initiative.
How this was made
The 30-second read
Why it matters
The new target suggests a 38% upside, which could prompt buying activity.
Market read
Fresh analyst price target may influence CI's short‑term price action.
What to watch
Potential regulatory or cost pressures not addressed in the note.
Background
Piper Sandler maintains an Overweight stance on Cigna, raising its price target to $370.
Ticker impact
Piper Sandler initiated a new $370 price target for Cigna Group, implying a 38% upside from the current price.
likely upward pressure as investors price in the new target
The target represents a material upside and is a fresh analyst recommendation.
Market effects
May lift sentiment in the health insurance sector.
US health‑care equities could see modest gains.
Limited to U.S. markets; no broader macro effect.
Counterpoint
Target may be overly optimistic if earnings growth slows.
Key entities
- companyCigna Group
U.S. health services insurer (ticker CI).
- analyst_firmPiper Sandler
Equity research firm issuing the rating.